Which hematologic cancer is most commonly associated with the presence of the Philadelphia chromosome?
সমাধান
সঠিক উত্তর: Option A
The Philadelphia chromosome (Ph chromosome) is a specific genetic abnormality resulting from a reciprocal translocation between chromosomes 9 and 22, denoted as t(9;22)(q34;q11). This translocation leads to the formation of the BCR-ABL fusion gene, which encodes a constitutively active tyrosine kinase. The activity of this abnormal kinase promotes uncontrolled cell proliferation and is a hallmark of certain hematologic malignancies.
Among the options given:
- Chronic myeloid leukemia (CML) is the hematologic cancer most commonly associated with the Philadelphia chromosome, found in over 90% of cases. The BCR-ABL fusion protein drives the pathogenesis of CML and serves as a key diagnostic marker and therapeutic target.
- While the Philadelphia chromosome can occasionally be found in acute lymphoblastic leukemia (ALL), particularly in adult cases, it is much less common compared to CML.
- Hairy cell leukemia and multiple myeloma are not associated with the Philadelphia chromosome.
In summary, the presence of the Philadelphia chromosome is classically linked to chronic myeloid leukemia, making it a critical diagnostic and prognostic feature in this disease.
Reference: Hematology: Basic Principles and Practice, 7th Edition, Volume 1, Chapter 56 / Page 1125
Among the options given:
- Chronic myeloid leukemia (CML) is the hematologic cancer most commonly associated with the Philadelphia chromosome, found in over 90% of cases. The BCR-ABL fusion protein drives the pathogenesis of CML and serves as a key diagnostic marker and therapeutic target.
- While the Philadelphia chromosome can occasionally be found in acute lymphoblastic leukemia (ALL), particularly in adult cases, it is much less common compared to CML.
- Hairy cell leukemia and multiple myeloma are not associated with the Philadelphia chromosome.
In summary, the presence of the Philadelphia chromosome is classically linked to chronic myeloid leukemia, making it a critical diagnostic and prognostic feature in this disease.
Reference: Hematology: Basic Principles and Practice, 7th Edition, Volume 1, Chapter 56 / Page 1125